Created by a worldwide team of scientists, business leaders, and attorneys, the Open COVID Pledge is a platform to license patents and copyrights freely to aid in the COVID-19 fight. But, if you make the pledge, how does it affect your IP now and more crucially after the pandemic ends?
Vadim Cherkasov and Jeffrey Safran of McCarter & English were joined by Melissa DeFrances, Counsel at Bristol-Myers Squibb Company for this session during the Health, Biotech and Pharma CLE Institute presented by the Association of Corporate Counsel Greater Philadelphia.